Abstract
2,4-Disubstituted pyrroles were polycondensed and tested for lipid-lowering effects in mice. Fluoro-substituted pyrrole monomers and polymers lowered total serum cholesterol by 30-35% and LDL-cholesterol by 47-64%. The lipidlowering effects were similar for polymers and their monomers, however, the polymers produced these effects at dosage concentrations 1/8th that of the monomers.
Keywords: Carboxylic acids, cholesterol, lipids, polymers, pyrroles, triglycerides, Lipid, Halophenyl Pyrroles, Cardiovascular disease, LDL, HDL, ezetimibe, colistipol, total serum cholesterol, regioselective synthesis
Letters in Drug Design & Discovery
Title: Lipid-Lowering Effects of Polymers Derived from Halophenyl Pyrroles
Volume: 8 Issue: 6
Author(s): Bruce S. Burnham, Joshua D. Berkowitz, Zachary Orr, Bryan McCranor, Mardel Cooper, Kurt McCann, Kyle Pillitteri, Jodi Hallback, Lisa-Marie Bergh, Larisa Gofman, Melissa Melendez, Justin M. Holub, Kenzo Morie and Charles E. Carraher
Affiliation:
Keywords: Carboxylic acids, cholesterol, lipids, polymers, pyrroles, triglycerides, Lipid, Halophenyl Pyrroles, Cardiovascular disease, LDL, HDL, ezetimibe, colistipol, total serum cholesterol, regioselective synthesis
Abstract: 2,4-Disubstituted pyrroles were polycondensed and tested for lipid-lowering effects in mice. Fluoro-substituted pyrrole monomers and polymers lowered total serum cholesterol by 30-35% and LDL-cholesterol by 47-64%. The lipidlowering effects were similar for polymers and their monomers, however, the polymers produced these effects at dosage concentrations 1/8th that of the monomers.
Export Options
About this article
Cite this article as:
S. Burnham Bruce, D. Berkowitz Joshua, Orr Zachary, McCranor Bryan, Cooper Mardel, McCann Kurt, Pillitteri Kyle, Hallback Jodi, Bergh Lisa-Marie, Gofman Larisa, Melendez Melissa, M. Holub Justin, Morie Kenzo and E. Carraher Charles, Lipid-Lowering Effects of Polymers Derived from Halophenyl Pyrroles, Letters in Drug Design & Discovery 2011; 8 (6) . https://dx.doi.org/10.2174/157018011795906839
DOI https://dx.doi.org/10.2174/157018011795906839 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Dietary Education on Cardiovascular Risk Factors in Rheumatoid Arthritis Patients
Current Rheumatology Reviews Smoking and Cognition
Current Drug Abuse Reviews Human Use of Leucoselect® Phytosome® with Special Reference to Inflammatory- Allergic Pathologies in Frail Elderly Patients
Current Pharmaceutical Design SAR, Cardiac Myocytes Protection Activity and 3D-QSAR Studies of Salubrinal and its Potent Derivatives
Current Medicinal Chemistry New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications
Current Radiopharmaceuticals Vascular Wall Responses to Angioplasty and Stenting: Endothelial Injury, Neointimal Hyperplasia and the Process of Restenosis
Vascular Disease Prevention (Discontinued) The Role of Berberine in the Multi-Target Treatment of Senile Dementia
Current Topics in Medicinal Chemistry Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia?
Current Drug Targets The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters Monoclonal Antibodies as Cancer Therapeutics
Recent Patents on Biotechnology Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Endothelial Dysfunction in the Hypertensive State: Mechanisms of Hypertensive Cardiovascular Complications
Current Hypertension Reviews Effects of Structured Treatment Interruptions on Metabolic, Anthropometric, Immunologic, and Quality of Life Outcomes in HIV-Positive Adults on HAART
Current HIV Research Lipid Management and Peripheral Arterial Disease
Current Drug Targets Effects of Onion Extract on Endogenous Vascular H2S and Adrenomedulin in Rat Atherosclerosis
Current Pharmaceutical Biotechnology High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
Current Topics in Medicinal Chemistry Serendipity of Erythromycin in the Management of Periprosthetic Inflammation
Current Drug Therapy Biomarkers in Aortic Valve Stenosis and their Clinical Significance in Transcatheter Aortic Valve Implantation
Current Medicinal Chemistry Polyphenols Effect on Circulating Lipids and Lipoproteins: From Biochemistry to Clinical Evidence
Current Pharmaceutical Design